Literature DB >> 20360312

Uremic thrombocytopathy is not about urea.

Gabor E Linthorst1, Hans J Avis, Marcel Levi.   

Abstract

Platelet dysfunction in renal failure is attributable to high levels of small, partly dialyzable molecules known as uremic toxins, hence the term "uremic thrombocytopathy." Although a variety of moieties contribute to platelet dysfunction or abnormal interactions between platelets and the vascular wall, urea remains a potential factor. Here, we studied three family members with familial azotemia, a rare autosomal dominant syndrome characterized by high plasma urea resulting from impaired urinary excretion but normal renal function otherwise. Platelet function, assessed in vitro and by traditional bleeding time, was normal in all individuals. Abnormal platelet function in patients with renal failure is not caused by high concentrations of urea.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20360312      PMCID: PMC2865735          DOI: 10.1681/ASN.2009111181

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  7 in total

Review 1.  Platelet dysfunction and end-stage renal disease.

Authors:  Dinkar Kaw; Deepak Malhotra
Journal:  Semin Dial       Date:  2006 Jul-Aug       Impact factor: 3.455

2.  [Familial proximal tubular azotemia. Elevated urea plasma levels in normal kidney function].

Authors:  T Armsen; V Glossmann; M Weinzierl; H H Edel
Journal:  Dtsch Med Wochenschr       Date:  1986-05-02       Impact factor: 0.628

Review 3.  Bleeding in renal failure.

Authors:  G Remuzzi
Journal:  Lancet       Date:  1988-05-28       Impact factor: 79.321

Review 4.  Platelet dysfunction in renal failure.

Authors:  Paola Boccardo; Giuseppe Remuzzi; Miriam Galbusera
Journal:  Semin Thromb Hemost       Date:  2004-10       Impact factor: 4.180

Review 5.  Urea transporters and renal function: lessons from knockout mice.

Authors:  Robert A Fenton
Journal:  Curr Opin Nephrol Hypertens       Date:  2008-09       Impact factor: 2.894

Review 6.  Treatment of bleeding in dialysis patients.

Authors:  Miriam Galbusera; Giuseppe Remuzzi; Paola Boccardo
Journal:  Semin Dial       Date:  2009 May-Jun       Impact factor: 3.455

7.  Familial azotemia. Impaired urea excretion despite normal renal function.

Authors:  C H Hsu; T W Kurtz; P U Massari; S A Ponze; B S Chang
Journal:  N Engl J Med       Date:  1978-01-19       Impact factor: 91.245

  7 in total
  7 in total

1.  Carbamylation of Integrin α IIb β 3: The Mechanistic Link to Platelet Dysfunction in ESKD.

Authors:  Veronika Binder; Barbara Chruścicka-Smaga; Brith Bergum; Stéphane Jaisson; Philippe Gillery; Joar Sivertsen; Tor Hervig; Marta Kaminska; Ronak Tilvawala; Venkatesh V Nemmara; Paul R Thompson; Jan Potempa; Hans-Peter Marti; Piotr Mydel
Journal:  J Am Soc Nephrol       Date:  2022-08-29       Impact factor: 14.978

2.  Platelet Function in CKD: A Systematic Review and Meta-Analysis.

Authors:  Constance C F M J Baaten; Marieke Sternkopf; Tobias Henning; Nikolaus Marx; Joachim Jankowski; Heidi Noels
Journal:  J Am Soc Nephrol       Date:  2021-05-03       Impact factor: 14.978

3.  Chronic Kidney Disease of Unknown Etiology (CKDu) in Sri Lanka: Hematological Changes and Pro-Inflammation Suggest Likely Predictors of Advance Disease, as Renal Outcomes Show Prevalent Normoalbuminuria.

Authors:  S H Nandana P Gunawickrama; K Imesha G Hewavitharana; P G Chandra L Nanayakkara; K B Suneetha Gunawickrama
Journal:  Diseases       Date:  2021-12-24

4.  Retrospective analysis of nontraumatic subdural hematoma incidence and outcomes in Egyptian patients with end-stage renal disease on hemodialysis.

Authors:  Ahmed Fayed; Ayman Tarek; Mohamed I Refaat; Sameh Abouzeid; Sohail Abdul Salim; Lajos Zsom; Tibor Fülöp; Karim M Soliman; Mohamed A Elmallawany
Journal:  Ren Fail       Date:  2021-12       Impact factor: 2.606

5.  Platelet Activity and Cardiovascular Risk in CKD and Peripheral Artery Disease.

Authors:  Lucas B Cofer; Qandeel H Soomro; Yuhe Xia; Elliot Luttrell-Williams; Khrystyna Myndzar; David M Charytan; Jeffrey S Berger
Journal:  Kidney Int Rep       Date:  2022-08-04

6.  Whole blood platelet aggregation and release reaction testing in uremic patients.

Authors:  Jay Zeck; Jason Schallheim; Susie Q Lew; Louis DePalma
Journal:  Biomed Res Int       Date:  2013-06-26       Impact factor: 3.411

7.  Coagulation Abnormalities in Renal Pathology of Chronic Kidney Disease: The Interplay between Blood Cells and Soluble Factors.

Authors:  Efthimia G Pavlou; Hara T Georgatzakou; Sotirios P Fortis; Konstantina A Tsante; Andreas G Tsantes; Efrosyni G Nomikou; Athanasia I Kapota; Dimitrios I Petras; Maria S Venetikou; Effie G Papageorgiou; Marianna H Antonelou; Anastasios G Kriebardis
Journal:  Biomolecules       Date:  2021-09-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.